Phase I, double-blind, placebo-controlled, multiple ascending dose, safety, tolerability, pharmacokinetic and central penetrance study of SRX251 capsules in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2008
At a glance
- Drugs SRX 251 (Primary)
- Indications Dysmenorrhoea; Premenstrual syndrome
- Focus Adverse reactions
- 12 Mar 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2007 New trial record.